Related Experiment Videos
Group B streptococcal conjugate vaccines
1Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
Insights
Bacterial conjugate vaccines link polysaccharides to proteins, significantly boosting immune responses in children. This approach has drastically reduced infections from Haemophilus influenzae type b and shows promise for preventing pneumococcal disease.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Unconjugated bacterial capsular polysaccharides are often poorly immunogenic in infants and young children.
- Covalent coupling of polysaccharides to proteins enhances immunogenicity by stimulating T cell-dependent immune responses.
Purpose of the Study:
- To highlight the impact of conjugate vaccines on childhood infectious diseases.
- To discuss the mechanism by which polysaccharide-protein conjugation enhances immunogenicity.
Main Methods:
- Review of existing literature on conjugate vaccine efficacy.
- Analysis of the immunological mechanisms underlying conjugate vaccine action.
Main Results:
- Haemophilus influenzae type b conjugate vaccines have dramatically reduced invasive infections in children.
- Pneumococcal conjugate vaccines, utilizing polysaccharide-protein conjugation, are expected to significantly decrease the incidence of invasive pneumococcal disease.
Conclusions:
- Polysaccharide-protein conjugate vaccines are highly effective in preventing bacterial infections in children.
- The development and implementation of conjugate vaccines represent a major advancement in pediatric public health.
Abstract:
Linkage of bacterial capsular polysaccharides to proteins to create conjugate vaccines has had a dramatic impact on the health of children. Although unconjugated polysaccharides are poorly immunogenic in infants and some older children and adults, their covalent coupling with proteins stimulates T cell dependent antigenic recognition that profoundly enhances immunogenicity. In the decade since the introduction and widespread use of Haemophilus influenzae type b polysaccharide conjugate vaccines in the United States, invasive H influenzae infections have become a rarity in childhood. Similarly, the conjugation of polysaccharides of Streptococcus pneumoniae to a derivative of diphtheria toxoid and the addition of pneumococcal conjugate vaccine to infant immunisation schedules carries with it promise for a similar decline in the incidence of invasive pneumococcal disease in paediatric patients.